JPH0565824B2 - - Google Patents
Info
- Publication number
- JPH0565824B2 JPH0565824B2 JP59086153A JP8615384A JPH0565824B2 JP H0565824 B2 JPH0565824 B2 JP H0565824B2 JP 59086153 A JP59086153 A JP 59086153A JP 8615384 A JP8615384 A JP 8615384A JP H0565824 B2 JPH0565824 B2 JP H0565824B2
- Authority
- JP
- Japan
- Prior art keywords
- slo
- solution
- latex
- casein
- aslo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004816 latex Substances 0.000 claims description 39
- 229920000126 latex Polymers 0.000 claims description 39
- 239000003153 chemical reaction reagent Substances 0.000 claims description 35
- 239000005018 casein Substances 0.000 claims description 26
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 26
- 235000021240 caseins Nutrition 0.000 claims description 26
- 238000012216 screening Methods 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 24
- 238000001179 sorption measurement Methods 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 5
- 230000001235 sensitizing effect Effects 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 35
- 230000000694 effects Effects 0.000 description 23
- 238000012360 testing method Methods 0.000 description 19
- 206010070834 Sensitisation Diseases 0.000 description 14
- 230000008313 sensitization Effects 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 12
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 11
- 229940098773 bovine serum albumin Drugs 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 7
- 230000004520 agglutination Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 101710179002 Hemolytic toxin Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- 206010061372 Streptococcal infection Diseases 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 108010075210 streptolysin O Proteins 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8615384A JPS60231167A (ja) | 1984-05-01 | 1984-05-01 | 診断用スクリ−ニング試薬及びその調製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8615384A JPS60231167A (ja) | 1984-05-01 | 1984-05-01 | 診断用スクリ−ニング試薬及びその調製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60231167A JPS60231167A (ja) | 1985-11-16 |
| JPH0565824B2 true JPH0565824B2 (zh) | 1993-09-20 |
Family
ID=13878790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8615384A Granted JPS60231167A (ja) | 1984-05-01 | 1984-05-01 | 診断用スクリ−ニング試薬及びその調製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60231167A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0735393U (ja) * | 1993-12-13 | 1995-06-27 | 有限会社フタバ産業 | ビデオカセットの郵送保管箱 |
| JP2013145172A (ja) * | 2012-01-13 | 2013-07-25 | Sysmex Corp | 副腎皮質刺激ホルモンの検出方法および吸着剤 |
| KR101428492B1 (ko) * | 2013-08-30 | 2014-08-12 | 린나이코리아 주식회사 | 과열 방지용 전선 거치대를 구비한 보일러 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0664061B2 (ja) * | 1987-02-27 | 1994-08-22 | イーストマン コダック カンパニー | 免疫反応性試薬、その製造法及び免疫反応性種を測定するためのその用途 |
| US4847199A (en) * | 1987-02-27 | 1989-07-11 | Eastman Kodak Company | Agglutination immunoassay and kit for determination of a multivalent immune species using a buffered salt wash solution |
| US5120643A (en) * | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
| CN106153887A (zh) * | 2016-05-27 | 2016-11-23 | 安徽伊普诺康生物技术股份有限公司 | 一种测定抗链球菌溶血素“o”的试剂盒 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5531960A (en) * | 1978-08-30 | 1980-03-06 | Nitsusui Seiyaku Kk | Latex sensing for cohesion reaction |
| JPS58172552A (ja) * | 1982-03-19 | 1983-10-11 | ベ−リングヴエルケ・アクチエンゲゼルシヤフト | 抗ストレプトリジンｏ−ラテツクス試薬およびその製法 |
-
1984
- 1984-05-01 JP JP8615384A patent/JPS60231167A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5531960A (en) * | 1978-08-30 | 1980-03-06 | Nitsusui Seiyaku Kk | Latex sensing for cohesion reaction |
| JPS58172552A (ja) * | 1982-03-19 | 1983-10-11 | ベ−リングヴエルケ・アクチエンゲゼルシヤフト | 抗ストレプトリジンｏ−ラテツクス試薬およびその製法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0735393U (ja) * | 1993-12-13 | 1995-06-27 | 有限会社フタバ産業 | ビデオカセットの郵送保管箱 |
| JP2013145172A (ja) * | 2012-01-13 | 2013-07-25 | Sysmex Corp | 副腎皮質刺激ホルモンの検出方法および吸着剤 |
| KR101428492B1 (ko) * | 2013-08-30 | 2014-08-12 | 린나이코리아 주식회사 | 과열 방지용 전선 거치대를 구비한 보일러 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60231167A (ja) | 1985-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dominguez et al. | Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine samples | |
| US5187065A (en) | Method and materials for detecting lyme disease | |
| WO2018129885A1 (zh) | 一种全血c反应蛋白检测试剂盒 | |
| JP2901296B2 (ja) | カンピロバクター・ピロリの高分子型細胞関連蛋白の調製法とカンピロバクター・ピロリ感染の血清学的検出のための用法 | |
| EP0064274B1 (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
| Gray et al. | Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen | |
| US4711841A (en) | Method for determining one or more antigens in a sample | |
| US4814247A (en) | Method for determining the existance and/or the monitoring of a pathological condition in a mammal | |
| JPH0565824B2 (zh) | ||
| CN113588967B (zh) | 一种生长刺激表达基因2蛋白的磁微粒化学发光检测试剂盒 | |
| Castellano et al. | Evaluation of commercially available diagnostic test kits for rubella | |
| JPH0214661B2 (zh) | ||
| Marx Jr et al. | Comparison of the enzyme-linked immunosorbent assay and double immunodiffusion test for the detection and quantitation of antibodies in farmer's lung disease | |
| DE69319240T2 (de) | In vitro-test für helicobacter pylori | |
| Beda-Maluga et al. | The detection of macroprolactin by precipitation and ultrafiltration methods | |
| CN111999506A (zh) | 一种d-二聚体检测试剂盒及其制备方法 | |
| EP0770875B1 (en) | Marker and reagent for diabetes mellitus and diabetes mellitus complication | |
| JPH07140144A (ja) | アレルゲン特異的ＩｇＥ抗体の測定方法および抗原抗体複合体の測定方法 | |
| Lagneau et al. | Fluid therapy directly interferes with immunoassay for cardiac troponin I | |
| US4090846A (en) | Indirect latex test for determination of fibrinogen degradation products | |
| Bonyadi et al. | Comparison of immunoblotting and elisa for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome | |
| JPS6243501B2 (zh) | ||
| DE69033944T2 (de) | Mittel zur direkten chemischen Bindung des D-Dimers aus einer biologischen Probe zwecks Diagnostik und Überwachung von thrombolytischen und hyperkoagulablen Zuständen | |
| Fayram et al. | Fluorescence immunoassay and passive latex agglutination as alternatives to hemagglutination inhibition for determining rubella immune status | |
| Lange et al. | INTERPRETATION OF FINDINGS IN THE CEREBROSPINAL FLUID: I. THE DEMENTIA PARALYTIGA FORMULA AND THE NECESSITY OF ITS QUANTITATIVE DIFFERENTIATION |